12 Best German Stocks to Buy According to Hedge Funds

Page 11 of 11

1. BioNTech SE (NASDAQ:BNTX)

Number of Hedge Fund Holders: 35

BioNTech SE (NASDAQ:BNTX) is a biotechnology company that develops and commercializes mRNA-based immunotherapies for cancer and infectious diseases. Its pipeline features vaccine and cancer therapeutic candidates that use mRNA technology to stimulate the immune system. It has numerous ongoing clinical trials and strategic collaborations to accelerate its development.

The company is prioritizing its Oncology segment, particularly focusing on two pan-tumor programs: mRNA cancer immunotherapies (FixVac and iNeST) and the bispecific anti-PD-L1/anti-VEGF antibody BNT327. The company believes these programs have the potential to improve patient outcomes across various tumor types and establish new standards of care. In 2024, the company made progress, which included initiating a Phase 3 trial for BNT327 in small-cell lung cancer and advancing multiple datasets for these programs.

The company expects to generate and share new clinical data from these priority programs in 2025. The acquisition of Biotheus is expected to accelerate and expand the global development of BNT327, while also strengthening the company’s clinical development and manufacturing capabilities in China. BioNTech SE (NASDAQ:BNTX) is investing in late-stage clinical trials, particularly in the adjuvant setting for its mRNA immunotherapies. It’s diversifying from its COVID-19 vaccine revenue stream to establish itself as a multi-product commercial oncology company.

While we acknowledge the growth potential of BioNTech SE (NASDAQ:BNTX), our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BNTX but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 11 of 11